President Joe Biden has issued an Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy (EO) that will likely have impacts on the pharmaceutical, energy, agriculture, and engineeringContinue Reading Bioeconomy Executive Order: A whole-of-government approach to advancing biotechnology and biomanufacturing
DLA Piper advises AiCure in US$24.5 million Series C financing
By Israel Group on
Posted in Articles
This investment will enable AiCure to accelerate its leading-edge commercial, engineering, and research and development activities in order to advance its research-grade data insights for life science companies.
The DLA Piper team representing AiCure was…
Continue Reading DLA Piper advises AiCure in US$24.5 million Series C financing